POST ARTICLE
JOIN FOR FREE
SiGN IN
Home COVAXIN® (BBV152) booster dose study shows Promising Results COVAXIN® (BBV152) booster dose study shows Promising Results

COVAXIN® (BBV152) booster dose study shows Promising Results

Bharat Biotech

Bharat Biotech, a global leader in vaccine innovation and developer of vaccines for infectious diseases, today announced the results from the highly anticipated trial studying the immunogenicity and safety of the COVAXIN® (BBV152) a whole-virion inactivated COVID-19 vaccine as a booster dose.

Experience the Speed: Now Available on Mobile!

Download EasyShiksha Mobile Apps from Android Play Store, Apple App Store, Amazon App Store, and Jio STB.

Easy Shiksha Mobile app

1+ million learners on the EasyShiksha App

Curious to learn more about EasyShiksha's services or need assistance?

Our team is always here to collaborate and address all your doubts.